WHO ICTRP trial
Safety, tolerability and Pharmacokinetics of multiple dose Youkenafil…
ChiCTR-IIR-17011814 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR-IIR-17011814 |
|---|---|
| Public title | Safety, tolerability and Pharmacokinetics of multiple dose Youkenafil Hydrochloride Tablet to healthy subjects |
| Scientific title | Safety, tolerability and Pharmacokinetics of multiple dose Youkenafil Hydrochloride Tablet to healthy subjects |
| Primary sponsor | Chinese PLA General Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | I (Phase I study) |
| Countries | China |
| Conditions | Erectile dysfunction |
| Interventions | 1:50mg;2:100mg;3:150mg |
| Registration date | Jun 30, 2017 |
| Target size | 1:12;2:12;3:12 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: